I am happy to announce that our last work is out in #CDD@SpringerNature.
It focuses on the role of #cmyc in #autophagy inhibition in #HPV tumors and its implication in response to chemotherapy.
I thank all the coauthors and @IEOufficiale. https://t.co/3VbH4eIpNq
Congratulations to @Cary_Weiss, postdoctoral fellow in the @srviswanathan Lab, on receiving a 2026 Damon Runyon-St. Jude Pediatric Cancer Research Fellowship for his project investigating translocation RCC! https://t.co/qp4EG7cxPt
🚨 New study! 🚨Excited to share our research on #translocationRCC#tRCC published in @NatMetabolism, in collaboration with @lironbarpeled. We reveal how the TFE3 fusion drives a key oxidative phosphorylation (OXPHOS) metabolic program in this kidney cancer. 1/ @DanaFarberNews
Thrilled to share our new paper in @ScienceMagazine, in which we identify p62/SQSTM1 as a critical regulator of micronuclei 🧬🔬🧫 #ScienceResearch
https://t.co/eimQJ3uqbf
Our study on sex differences in Xp11 translocation renal cell carcinoma is out @CellCellPress! We ascribe a genetic basis to the female bias in tRCC, which is driven by a translocation of the TFE3 gene on the X chromosome. w Zhang lab @danafarbernews https://t.co/DMhSmlY8xU 🧵1/
Our study on sex differences in Xp11 translocation renal cell carcinoma is out @CellCellPress! We ascribe a genetic basis to the female bias in tRCC, which is driven by a translocation of the TFE3 gene on the X chromosome. w Zhang lab @danafarbernews https://t.co/DMhSmlY8xU 🧵1/
I am happy to announce that our last work is out in #CDD@SpringerNature.
It focuses on the role of #cmyc in #autophagy inhibition in #HPV tumors and its implication in response to chemotherapy.
I thank all the coauthors and @IEOufficiale. https://t.co/3VbH4eIpNq